{"nct_id":"NCT01252940","title":"Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF","status":"COMPLETED","status_verified_date":"2015-10","start_date":"2010-11","start_date_type":null,"primary_completion_date":"2012-01","primary_completion_date_type":"ACTUAL","completion_date":"2014-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}